These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 39231766)

  • 21. [Chinese expert consensus on the diagnosis and treatment of adult T-cell leukemia/lymphoma (2024)].
    ;
    Zhonghua Nei Ke Za Zhi; 2024 Dec; 63(12):1196-1204. PubMed ID: 39622724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case report: CD7-targeted autologous CAR-T therapy for the treatment of T-cell acute lymphoblastic leukemia undergoing allogeneic peripheral blood stem cell transplantation in the long-term follow-up.
    Li LL; Xia YP; Li Q; Wang P; Sun PP; Wang XG; Zhang R
    Front Immunol; 2024; 15():1469251. PubMed ID: 39620223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interventions for supporting pregnant women's decision-making about mode of birth after a caesarean.
    Horey D; Kealy M; Davey MA; Small R; Crowther CA
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD010041. PubMed ID: 23897547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tamoxifen for adults with hepatocellular carcinoma.
    Naing C; Ni H; Aung HH
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes as a risk factor for tuberculosis disease.
    Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD016013. PubMed ID: 39177079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment and treatment of gesture in neurogenic communication disorders: An international survey of practice.
    Caute A; Roper A; Dipper L; Stark BC
    Int J Lang Commun Disord; 2025; 60(1):e13136. PubMed ID: 39584407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cells.
    Park DH; Bhojnagarwala PS; Liaw K; Bordoloi D; Tursi NJ; Zhao S; Binder ZA; O'Rourke D; Weiner DB
    J Immunother Cancer; 2024 Dec; 12(12):. PubMed ID: 39622583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia.
    Kimura H; Onozawa M; Yoshida S; Miyashita N; Yokoyama S; Matsukawa T; Hirabayashi S; Goto H; Endo T; Oguri S; Fujisawa S; Mori A; Kondo T; Hidaka D; Okada K; Ota S; Kakinoki Y; Tsutsumi Y; Yamamoto S; Miyagishima T; Hashiguchi J; Nagashima T; Ibata M; Wakasa K; Haseyama Y; Fujimoto K; Ishihara T; Sakai H; Teshima T
    Ann Hematol; 2023 Nov; 102(11):3103-3113. PubMed ID: 37597110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the role of PARP1 inhibition in enhancing antibody-drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactions.
    Ghelli Luserna di Rorà A; Jandoubi M; Padella A; Ferrari A; Marranci A; Mazzotti C; Olimpico F; Ghetti M; Ledda L; Bochicchio MT; Paganelli M; Zanoni M; Cafaro A; Servili C; Galimberti S; Gottardi M; Rondoni M; Endri M; Onofrillo D; Audisio E; Marconi G; Simonetti G; Martinelli G
    J Transl Med; 2024 Nov; 22(1):1062. PubMed ID: 39587643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of the Modified St. Jude Total XV Protocol in Turkish Children with Newly Diagnosed Acute Lymphoblastic Leukemia: A Single-Center Retrospective Analysis.
    Yılmaz H; Aytaç S; Kuşkonmaz B; Çetinkaya D; Ünal Ş; Gümrük F
    Turk J Haematol; 2024 Aug; 41(3):146-159. PubMed ID: 38994780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
    Shah BD; Ghobadi A; Oluwole OO; Logan AC; Boissel N; Cassaday RD; Leguay T; Bishop MR; Topp MS; Tzachanis D; O'Dwyer KM; Arellano ML; Lin Y; Baer MR; Schiller GJ; Park JH; Subklewe M; Abedi M; Minnema MC; Wierda WG; DeAngelo DJ; Stiff P; Jeyakumar D; Feng C; Dong J; Shen T; Milletti F; Rossi JM; Vezan R; Masouleh BK; Houot R
    Lancet; 2021 Aug; 398(10299):491-502. PubMed ID: 34097852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of antibody therapies in treating relapsed chronic lymphocytic leukemia: a review.
    Witkowska M; Majchrzak A; Robak P; Wolska-Washer A; Robak T
    Expert Opin Biol Ther; 2024 Nov; 24(11):1233-1244. PubMed ID: 39364800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia].
    Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596
    [No Abstract]   [Full Text] [Related]  

  • 34. Bispecific antibodies in clinical practice: Understanding recent advances and current place in cancer treatment landscape.
    Verma V; Sharma G
    Clin Exp Med; 2024 Nov; 25(1):11. PubMed ID: 39607562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of immunological aging on T cell-mediated therapies in older adults with multiple myeloma and lymphoma.
    Ullrich F; Bröckelmann PJ; Turki AT; Khan AM; Chiru ED; Vetter M; Tresckow BV; Wirth R; Cordoba R; Ortiz-Maldonado V; Fülöp T; Neuendorff NR
    J Immunother Cancer; 2024 Dec; 12(12):. PubMed ID: 39622581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Quality Approach to Blinatumomab Delivery in Pediatric Oncology: A Children's Oncology Group Study.
    Montgomery KE; Zupanec S; Yun C; Okada M; Kubaney H; Feehily E; Withycombe JS
    J Pediatr Hematol Oncol Nurs; 2024; 41(5):324-335. PubMed ID: 39245851
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia.
    Tan K; Xu J; Chen C; Vincent T; Pölönen P; Hu J; Yoshimura S; Yu W; Sussman J; Chen CH; Li E; Diorio C; Shraim R; Newman H; Uppuluri L; Li A; Chen G; Bandyopadhyay S; Wu D; Ding YY; Xu J; Lim T; Hsu M; Thadi A; Ahn KJ; Wu CY; Peng J; Sun Y; Wang A; Mehta R; Frank D; Meyer L; Loh M; Raetz E; Chen Z; Wood B; Devidas M; Dunsmore K; Winter S; Chang TC; Wu G; Pounds S; Zhang N; Carroll W; Hunger S; Bernt K; Yang J; Mullighan C; Teachey D
    Res Sq; 2023 Oct; ():. PubMed ID: 37961674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Consensus on immunotherapy for small cell lung cancer(2024 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2024 Dec; 46():1241-1251. PubMed ID: 39632256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells.
    Urbanska K; Lynn RC; Stashwick C; Thakur A; Lum LG; Powell DJ
    J Transl Med; 2014 Dec; 12():347. PubMed ID: 25496493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.